Literature DB >> 9918747

Effect of novel mixed ETA/ETB antagonists on responses to ET-1 in human small muscular pulmonary arteries.

M R MacLean1, C C Docherty, K M McCulloch, I Morecroft.   

Abstract

Selective ETA and ETB receptor antagonists do not fully inhibit responses to ET-1 in human small pulmonary arteries. Here, we have compared the influence of the novel mixed ETA/ETB antagonists SB/217242, SB/234551 and SB/209670 on ET-1-mediated vasoconstriction in these vessels. ET-1 was a potent vasoconstrictor (pEC50: 8.14+/-0.05, n=5) and the concentration-response curve to ET-1 was biphasic in nature. All three mixed antagonists (1 microM) inhibited the responses to ET-1, abolishing the biphasic form of the concentration response curve. The order of potency was SB 209670>SB 234551>/=SB 217242 with estimated pKb values of 8.0+/-0.20, 6.8+/-0.17 and 6. 6+/-0.11 respectively (n=3-5). Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9918747     DOI: 10.1006/pupt.1998.0129

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  5 in total

1.  Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications.

Authors:  H Ulrich; P Majumder
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

3.  Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone.

Authors:  Graeme A Deuchar; Andrew Docherty; Margaret R MacLean; Martin N Hicks
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension.

Authors:  Olga Rafikova; Ruslan Rafikov; Sanjiv Kumar; Shruti Sharma; Saurabh Aggarwal; Frank Schneider; Danny Jonigk; Stephen M Black; Stevan P Tofovic
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

5.  Role of endothelin receptor antagonist; bosentan in cisplatin-induced nephrotoxicity in ovariectomized estradiol treated rats.

Authors:  Alieh Zahedi; Mehdi Nematbakhsh; Maryam Moeini; Ardeshir Talebi
Journal:  J Nephropathol       Date:  2015-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.